Southern Illinois School of Medicine is looking for individuals to take part in a national multi-state study of the drug Gammagard. The drug is being evaluated for its safety and effectiveness in the treatment of Alzheimers disease. Limited studies say the drug may help stabilize the debilitating disease for up to three years.
Individuals who have been diagnosed with mile to moderate Alzheimers disease who would like to participate in the trail may contact Barbara Lokaitis at 545-9737 weekdays.